-
Apixaban approval; new dental clinical practice guideline; apixaban for VTE; aspirin resistance; tamoxifen treatment; and FDA actions.
-
The national epidemic of substance abuse naturally imparts uncertainty and fear in the decision-making process regarding the prescribing of opioids for patients in pain. Statistics alone substantiate the need to validate our decisions with a documented plan of care.
-
-
-
-
Myocardial perfusion imaging (MPI) refers to the utilization of radiotracers to image regional myocardial perfusion from coronary artery blood flow to the heart muscle. Used effectively, MPI can provide the clinician with a noninvasive technique that yields both important diagnostic and powerful prognostic information regarding the functional significance of anatomic coronary artery disease.
-
A second factor XA inhibitor (novel oral anticoagulant, NOAC), after rivaroxaban, has been approved for prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF). Apixaban is marketed by Bristol-Myers Squibb and Pfizer as Eliquis.
-
I just had a patient present for consultation, concerned hed transmitted herpes simplex virus (HSV) to two new sexual partners, despite a lack of symptoms or obvious lesions, and expressing concern about the adequacy of suppressive acyclovir therapy. He had tried to convince both new partners it was not him! I had to disappoint him.
-
Stopping smoking before the age of 40 avoids more than 90% of the excess mortality caused by smoking in women.
-
Long-term Prevention of Recurrent DVT; Marijuana and the Risk of Schizophrenia; Losartan Improves Erectile Function in Diabetics